Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.

Melanoma Survival Improved by Memory Killer Cells

Credit: Christoph Burgstedt/Getty Images Researchers at Karolinska Institutet in Sweden and the University of Copenhagen in Denmark have demonstrated how memory killer cells are formed

June 7, 2023

FDA, DEA Heads Acknowledge ADHD Drug Shortage in Public Letter

In a letter to the American public, the heads of the Drug Enforcement Administration (DEA) and FDA acknowledged ongoing stimulant drug shortages and recounted their

August 3, 2023

FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC

Ahead of a meeting of the Oncologic Drugs Advisory Committee on Thursday, FDA reviewers raised a host of concerns about the confirmatory trial data for

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.